CollPlant Biotechnologies Ltd. CLGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -13.00M | -13.87M | |
| Total Depreciation and Amortization | -- | -- | 970.00K | 1.00M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | 1.48M | 1.82M | |
| Change in Net Operating Assets | -- | -- | 34.00K | -963.00K | |
| Cash from Operations | -- | -- | -10.52M | -12.01M | |
| Capital Expenditure | -- | -- | -211.00K | -410.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | 2.00K | 2.00K | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 0.00 | -57.00K | |
| Cash from Investing | -- | -- | -209.00K | -465.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | 3.10M | 0.00 | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -- | 3.10M | 0.00 | |
| Foreign Exchange rate Adjustments | -- | -- | 140.00K | -18.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -7.49M | -12.49M | |